Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara

Clinical trial NCT03896737 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03896737
Sponsor: European Myeloma Network B.V.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2019-04-16
Primary completion: 2026-06-30
Enrollment: 401

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.